DECIPHERA PHARMACEUTICALS, INC.
DECIPHERA PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 6497832, and its current status with Delaware Division of Corporations is active. The company was incorporated on 8 January 2017 and lists its registered address as United States. 5 shareholders are on record for DECIPHERA PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for DECIPHERA PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Deerfield Management Company, L.P. (Series C), holding 14.3% — the largest recorded stake — followed by Blackrock Inc. at 11.7%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 20 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 14.3% | Delaware Division of Corporations | |
| Blackrock Inc. | 11.7% | Delaware Division of Corporations | |
| Redmile Group, LLC | 10.4% | Delaware Division of Corporations | |
| Armistice Capital, LLC | 9.7% | Delaware Division of Corporations | |
| Vanguard Group Inc | 9.4% | Delaware Division of Corporations |
Officers
5
The President, Ceo & Director of DECIPHERA PHARMACEUTICALS, INC. currently on record is Steven L. Hoerter; five officers are currently on record for DECIPHERA PHARMACEUTICALS, INC., filed with Delaware Division of Corporations.
The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at DECIPHERA PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
DECIPHERA PHARMACEUTICALS, INC. sits 1 level below its ultimate parent, ONO PHARMACEUTICAL CO., LTD., registered in Japan. 8 subsidiaries are recorded beneath it, across 2 jurisdictions. The full chain up to ONO PHARMACEUTICAL CO., LTD. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by DECIPHERA PHARMACEUTICALS, INC.'s own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 8 subsidiaries span United States, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 8 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
ONO PHARMACEUTICAL CO., LTD.
Japan
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns DECIPHERA PHARMACEUTICALS, INC.?
Five shareholders are currently on record for DECIPHERA PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Deerfield Management Company, L.P. (Series C), holding 14.3% — the largest recorded stake — followed by Blackrock Inc. at 11.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is DECIPHERA PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for DECIPHERA PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does DECIPHERA PHARMACEUTICALS, INC. have on record?
5 shareholders are shown on record for DECIPHERA PHARMACEUTICALS, INC.. The register reports 20 in total; only the top 5 by holding are shown here.
What is DECIPHERA PHARMACEUTICALS, INC.'s company registration number?
DECIPHERA PHARMACEUTICALS, INC.'s registration number is 6497832, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is DECIPHERA PHARMACEUTICALS, INC. still an active company?
DECIPHERA PHARMACEUTICALS, INC.'s status on Delaware Division of Corporations is listed as active.
When was DECIPHERA PHARMACEUTICALS, INC. incorporated?
DECIPHERA PHARMACEUTICALS, INC. was incorporated on 8 January 2017, according to Delaware Division of Corporations.
What is DECIPHERA PHARMACEUTICALS, INC.'s registered address?
The registered address on file for DECIPHERA PHARMACEUTICALS, INC. is United States.
Who are the officers/directors of DECIPHERA PHARMACEUTICALS, INC.?
The President, Ceo & Director of DECIPHERA PHARMACEUTICALS, INC. currently on record is Steven L. Hoerter; five officers are currently on record for DECIPHERA PHARMACEUTICALS, INC., filed with Delaware Division of Corporations. Management authority at DECIPHERA PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does DECIPHERA PHARMACEUTICALS, INC. have a parent company or subsidiaries?
DECIPHERA PHARMACEUTICALS, INC. sits 1 level below its ultimate parent, ONO PHARMACEUTICAL CO., LTD., registered in Japan. 8 subsidiaries are recorded beneath it, across 2 jurisdictions. Those 8 subsidiaries span United States, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 8 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to DECIPHERA PHARMACEUTICALS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to DECIPHERA PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access DECIPHERA PHARMACEUTICALS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like DECIPHERA PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.